These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1348064)

  • 1. The rt-PA versus streptokinase. Controversy--I.
    Lenfant C
    J Am Coll Cardiol; 1992 Apr; 19(5):1116. PubMed ID: 1348064
    [No Abstract]   [Full Text] [Related]  

  • 2. The rt-PA versus streptokinase. Controversy--II.
    Braunwald E; Knatterud G; Passamani E
    J Am Coll Cardiol; 1992 Apr; 19(5):1116-9. PubMed ID: 1552103
    [No Abstract]   [Full Text] [Related]  

  • 3. The rt-PA versus streptokinase controversy--IV.
    Swan HJ
    J Am Coll Cardiol; 1992 Apr; 19(5):1120. PubMed ID: 1552105
    [No Abstract]   [Full Text] [Related]  

  • 4. The rt-PA versus streptokinase controversy--III.
    Sherry S; Marder VJ
    J Am Coll Cardiol; 1992 Apr; 19(5):1119-20. PubMed ID: 1552104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?
    Collen D
    Ann Intern Med; 1990 Apr; 112(7):529-38. PubMed ID: 2107781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase versus alteplase in acute myocardial infarction.
    Friedman HS
    J R Soc Med; 1996 Aug; 89(8):427-30. PubMed ID: 8795494
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary angioplasty or thrombolysis for acute myocardial infarction?
    Armstrong PW
    Lancet; 2003 Mar; 361(9361):966-7; author reply 967-8. PubMed ID: 12648990
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptokinase versus recombinant tissue-type plasminogen activator.
    Guharoy SR
    DICP; 1991 Nov; 25(11):1271-2. PubMed ID: 1763549
    [No Abstract]   [Full Text] [Related]  

  • 12. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
    Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in acute myocardial infarction: an emergency department perspective.
    Walters BL
    Henry Ford Hosp Med J; 1991; 39(3-4):184-94. PubMed ID: 1687142
    [No Abstract]   [Full Text] [Related]  

  • 16. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing patients after myocardial infarction.
    Cohen LS
    Hosp Pract (Off Ed); 1990 Mar; 25(3):49-60. PubMed ID: 1968904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in myocardial infarction (TIMI): update 1987.
    Mueller HS
    Klin Wochenschr; 1988; 66 Suppl 12():93-101. PubMed ID: 3126350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction: a meta-analysis.
    Vaitkus PT
    Clin Cardiol; 1995 Jan; 18(1):35-8. PubMed ID: 7704983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thrombolysis in myocardial infarction (TIMI) trial phase I and phase IIA pilot results. Implications for nursing.
    Brewer-Senerchia C
    Prog Cardiovasc Nurs; 1988; 3(4):128-36. PubMed ID: 2974593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.